CN107987159B - 一种使用大剂量dna免疫技术免疫动物使血清中抗体滴度提高的方法 - Google Patents
一种使用大剂量dna免疫技术免疫动物使血清中抗体滴度提高的方法 Download PDFInfo
- Publication number
- CN107987159B CN107987159B CN201711214901.0A CN201711214901A CN107987159B CN 107987159 B CN107987159 B CN 107987159B CN 201711214901 A CN201711214901 A CN 201711214901A CN 107987159 B CN107987159 B CN 107987159B
- Authority
- CN
- China
- Prior art keywords
- adjuvant
- serum
- animal
- immunization
- mixed solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003053 immunization Effects 0.000 title claims abstract description 67
- 238000002649 immunization Methods 0.000 title claims abstract description 62
- 241001465754 Metazoa Species 0.000 title claims abstract description 60
- 210000002966 serum Anatomy 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 31
- 239000002671 adjuvant Substances 0.000 claims abstract description 62
- 102000036639 antigens Human genes 0.000 claims abstract description 38
- 108091007433 antigens Proteins 0.000 claims abstract description 38
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 28
- 239000011259 mixed solution Substances 0.000 claims abstract description 26
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 26
- 238000002347 injection Methods 0.000 claims abstract description 22
- 239000007924 injection Substances 0.000 claims abstract description 22
- 239000000427 antigen Substances 0.000 claims abstract description 15
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 14
- 239000013613 expression plasmid Substances 0.000 claims abstract description 9
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims abstract description 7
- 241000700159 Rattus Species 0.000 claims description 38
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 17
- 239000013612 plasmid Substances 0.000 claims description 6
- 241000699670 Mus sp. Species 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000007920 subcutaneous administration Methods 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 4
- 230000028993 immune response Effects 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 8
- 210000003462 vein Anatomy 0.000 description 7
- 230000036039 immunity Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000010171 animal model Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012453 sprague-dawley rat model Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- MMHMYFWOECSGDR-UHFFFAOYSA-N 2,5-dimethoxybenzenesulfonamide Chemical compound COC1=CC=C(OC)C(S(N)(=O)=O)=C1 MMHMYFWOECSGDR-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
Abstract
Description
免疫方式 | IgG2a | IgG2b |
DNA免疫(67个) | 26 | 41 |
蛋白免疫(64个) | 59 | 1 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711214901.0A CN107987159B (zh) | 2017-11-28 | 2017-11-28 | 一种使用大剂量dna免疫技术免疫动物使血清中抗体滴度提高的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711214901.0A CN107987159B (zh) | 2017-11-28 | 2017-11-28 | 一种使用大剂量dna免疫技术免疫动物使血清中抗体滴度提高的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107987159A CN107987159A (zh) | 2018-05-04 |
CN107987159B true CN107987159B (zh) | 2021-06-22 |
Family
ID=62033647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711214901.0A Active CN107987159B (zh) | 2017-11-28 | 2017-11-28 | 一种使用大剂量dna免疫技术免疫动物使血清中抗体滴度提高的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107987159B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110669133A (zh) * | 2019-10-18 | 2020-01-10 | 普健生物(武汉)科技有限公司 | 利用尾静脉注射进行基因免疫开发小鼠单克隆抗体的方法 |
CN114748614A (zh) * | 2021-12-27 | 2022-07-15 | 上海药明生物医药有限公司 | 一种利用无针注射器进行动物免疫的方法 |
CN114836416B (zh) * | 2022-05-24 | 2023-10-31 | 安徽环球基因科技有限公司 | 一种CpG ODN佐剂及其在抗体生产中的应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1299288A (zh) * | 1998-03-09 | 2001-06-13 | 史密丝克莱恩比彻姆生物有限公司 | 联合疫苗组合物 |
CN1387443A (zh) * | 1999-09-07 | 2002-12-25 | 史密丝克莱恩比彻姆生物有限公司 | 联合疫苗组合物 |
CN101559224A (zh) * | 2008-04-18 | 2009-10-21 | 北京生物制品研究所 | 脊髓灰质炎疫苗 |
CN101559225A (zh) * | 2008-04-18 | 2009-10-21 | 北京生物制品研究所 | 脑膜炎球菌疫苗 |
CN105214083A (zh) * | 2014-06-26 | 2016-01-06 | 长春华普生物技术有限公司 | 含有CpG寡核苷酸的药物组合物 |
-
2017
- 2017-11-28 CN CN201711214901.0A patent/CN107987159B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1299288A (zh) * | 1998-03-09 | 2001-06-13 | 史密丝克莱恩比彻姆生物有限公司 | 联合疫苗组合物 |
CN1387443A (zh) * | 1999-09-07 | 2002-12-25 | 史密丝克莱恩比彻姆生物有限公司 | 联合疫苗组合物 |
CN101559224A (zh) * | 2008-04-18 | 2009-10-21 | 北京生物制品研究所 | 脊髓灰质炎疫苗 |
CN101559225A (zh) * | 2008-04-18 | 2009-10-21 | 北京生物制品研究所 | 脑膜炎球菌疫苗 |
CN105214083A (zh) * | 2014-06-26 | 2016-01-06 | 长春华普生物技术有限公司 | 含有CpG寡核苷酸的药物组合物 |
Non-Patent Citations (1)
Title |
---|
Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen;Na Zhan等;《Virology Journal》;20111104;第8卷;507号文章 * |
Also Published As
Publication number | Publication date |
---|---|
CN107987159A (zh) | 2018-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ertl et al. | Sendai virus-specific T-cell clones: induction of cytolytic T cells by an anti-idiotypic antibody directed against a helper T-cell clone. | |
CN107987159B (zh) | 一种使用大剂量dna免疫技术免疫动物使血清中抗体滴度提高的方法 | |
CN101928346B (zh) | 一种抗人组织激肽释放酶单克隆抗体及其制备 | |
CN102636644A (zh) | 检测禽白血病群特异性抗原的双抗体夹心elisa试剂盒 | |
CN103003305A (zh) | 癌症疫苗 | |
CN102304181A (zh) | 一种j亚群禽白血病病毒表面蛋白的单克隆抗体及其制备方法 | |
CN1560081A (zh) | 用能产生人IgGl重链-κ轻链小鼠作为制备人源化单克隆抗体和应用 | |
CN101451145A (zh) | 基于t细胞表位的结核基因疫苗及其制备方法和应用 | |
CN103724413B (zh) | 旋毛虫副肌球蛋白b细胞抗原表位8a1及其应用 | |
CN102747044A (zh) | 一种抗猪伪狂犬病病毒的杂交瘤细胞系及其制备方法和一种单克隆抗体及其应用 | |
JP2012505229A (ja) | 自己抗イディオタイプワクチンを用いてb細胞イディオタイプに対する持続的免疫応答を誘導するための方法 | |
CN1438245A (zh) | 传染性病原体相关蛋黄抗体的制备及应用 | |
Kantele et al. | Humoral immune response to keyhole limpet haemocyanin, the protein carrier in cancer vaccines | |
CN102304180A (zh) | 禽网状内皮组织增生症病毒囊膜蛋白的单克隆抗体及其制备方法 | |
MacDonald et al. | Efficacy of a single dose hepatitis B depot vaccine | |
AU2017275663A1 (en) | Modification of engineered influenza hemagglutinin polypeptides | |
CN103159855B (zh) | 融合蛋白及其用途、其抗疟疾疫苗和抗体 | |
CN101891825B (zh) | 乙肝核心蛋白与结核抗原或抗原片段的重组融合蛋白及用途 | |
CN102813920A (zh) | 一种疫苗佐剂 | |
CN101675994B (zh) | 治疗性疫苗制剂 | |
RU2371196C1 (ru) | Способ определения предельно допустимой антигенной нагрузки, стимулирующей продукцию гуморальных антител | |
CA2940065A1 (en) | Method for the rapid production of high affinity monoclonal anitibodies | |
CN102827285B (zh) | 一组鼠特异性抗生育作用的多肽 | |
Prabhu et al. | HIV immunogens: affinity is key | |
CN1785425A (zh) | 牙鲆淋巴囊肿病的多肽疫苗的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180810 Address after: 200131 701, 7 floor, 2 Hua Jing Road, Pudong New Area, Shanghai. Applicant after: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Applicant after: WUXI APPTEC BIOPHARMACEUTICALS CO., LTD. Address before: 200131 701, 7 floor, 2 Hua Jing Road, Pudong New Area, Shanghai. Applicant before: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. |
|
CB02 | Change of applicant information |
Address after: 200131 701, 7 floor, 2 Hua Jing Road, Pudong New Area, Shanghai. Applicant after: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Applicant after: Wuxi Yaoming Biotechnology Co., Ltd. Address before: 200131 701, 7 floor, 2 Hua Jing Road, Pudong New Area, Shanghai. Applicant before: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Applicant before: WUXI APPTEC BIOPHARMACEUTICALS CO., LTD. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200103 Address after: 200131 A location of 301 parts of 2 building, 299 Fu Tai Road, Pudong New Area Free Trade Zone, Shanghai Applicant after: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Applicant after: Wuxi Yaoming Biotechnology Co., Ltd. Applicant after: Wuxi Yaoming coupling Biotechnology Co., Ltd Address before: 200131 Shanghai city Pudong New Area Huajing Road No. 2 7 floor room 701 Applicant before: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Applicant before: Wuxi Yaoming Biotechnology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210518 Address after: 201403 room 2481, building 1, 1150 Lanfeng Road, Fengxian District, Shanghai Applicant after: Shanghai Yaoming Biomedical Co.,Ltd. Address before: 200131 Shanghai Pudong New Area pilot Free Trade Zone Applicant before: WUXI BIOLOGICS (SHANGHAI) Co.,Ltd. Applicant before: Wuxi Yaoming Biotechnology Co.,Ltd. Applicant before: Wuxi Yaoming coupling Biotechnology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |